Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
Open Access
- 1 June 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 27 (6) , 1554-1562
- https://doi.org/10.1002/hep.510270613
Abstract
As in other tumors, the assessment of microvessel density (MVD) in hepatocellular carcinoma (HCC) may be essential to perform an effective anti-angiogenic therapy for this tumor. The relationship between vascular endothelial growth factor (VEGF) and MVD of HCC as well as the surrounding liver remains to be elucidated. In 71 patients who had undergone curative hepatic resection for HCC, MVD and VEGF expressions were evaluated for HCC and the liver by quantitative reverse-transcription polymerase chain reaction (RT-PCR) and/or immunostaining. The intensity and extent of VEGF immunoreactivity were evaluated using a computer image analyzer-cell analysis system (CAS). Angiographic data were re-evaluated and compared with MVD in 50 tumors. Tumoral MVD was significantly correlated with tumor capsule formation (t test, P = .0016). Small HCCs (≤2 cm) had a significantly lower MVD compared with moderate-sized HCCs (2-5 cm) (t test, P = .016), and the MVD of large HCCs was relatively lower than that of moderate tumors. Tumor vascularity on angiography was not correlated with the MVD. Neither VEGF mRNA levels nor protein expression in HCC were correlated with the tumoral MVD or any histopathological features of the tumor. However, cirrhotic livers had significantly higher MVD and VEGF expressions compared with noncirrhotic livers (t test, P = .0015 and P = .047, respectively). Only the MVD of tumor was significantly correlated with intrahepatic recurrence (t test, P = .0048) and disease-free survival (DFS) rates (log rank test, P = .0035). Moreover, the MVD was an independent predictor for DFS by multivariate analysis (χ2 test, P = .03). In conclusion, the MVD in HCC may be involved in the dismal prognosis of this tumor, and VEGF may be associated with the angiogenic process of the cirrhotic liver, but not with the angiogenesis of HCC.Keywords
This publication has 20 references indexed in Scilit:
- Vascular endothelial growth factor expression in primary esophageal squamous cell carcinomaCancer, 1997
- Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancerSurgery, 1996
- Prognostic value of vascular endothelial growth factor expression in gastric carcinomaCancer, 1996
- The Relationship of Angiogenesis to Biological Activity in Human Squamous Cell Carcinomas of the Head and NeckAnnals of Plastic Surgery, 1994
- Identification and Localization of Alternately Spliced mRNAs for Vascular Endothelial Growth Factor in Human Uterus and Estrogen Regulation in Endometrial Carcinoma Cell Lines1Biology of Reproduction, 1993
- Liver Resection for Hepatocellular Carcinoma Results of 229 Consecutive Patients During 11 YearsAnnals of Surgery, 1993
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Gangliosides, copper ions and angiogenic capacity of adult tissuesCancer and Metastasis Reviews, 1990
- An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinomaCancer, 1990